Impermeability of the blood‐cerebrospinal fluid barrier to 1‐deamino‐8‐D‐arginine‐vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The passage of the vasopressin analogue, 1‐deamino‐8‐D‐arginine‐vasopressin (DDAVP) into the cerebrospinal fluid (CSF) following intravenous (i.v.) administration was studied in human subjects. After i.v. injection of DDAVP, resulting in plasma levels exceeding normal plasma concentrations of vasopressin (AVP) by 100‐fold, serial blood and ventricular CSF specimens were sampled during 2 h. Plasma and CSF were analysed by radioimmunoassay using two different AVP antisera: one specific against natural AVP and another cross‐reacting 100% with DDAVP. No changes in the joint concentrations of DDAVP + AVP in CSF were found following i.v. infusion of DDAVP when compared with the concentration before the infusion. Neither was any difference between CSF concentrations of AVP and DDAVP + AVP observed at any sampling time following the i.v. DDAVP administration. Hence, it is concluded that no measurable amounts of DDAVP can be found in the CSF for up to 2 h after i.v. administration of the peptide, and that for all practical purposes a blood‐CSF barrier to DDAVP exists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat
Buijs, R. M., Swaab, D. F., Dogterom, J., & van Leeuwen, F. W. (1978) · Cell and Tissue Research · doi:10.1007/bf00224932 · Cited by 1,029
Research works printed but not linked: 35
- 10.1007/978-1-4684-1039-6_43 · DOI
- 10.1210/jcem-50-2-364 · DOI · Paper page
- Hammer M., 1982, Vasopressin in the cerebrospinal fluid of patients with normal pressure hydrocephalus and benign intracranial hypertension, Acta Endocrinol, 100, 211
- Simon‐Oppermann C., 1983, Vasopressin in blood and third ventricle CSF of dogs in chronic experiments, Am J Physiol, 245, R541
- 10.1136/jnnp.44.3.216 · DOI
- 10.1212/WNL.32.11.1255 · DOI
- 10.1002/ana.410150506 · DOI
- 10.1002/ana.410090212 · DOI
- 10.1016/0028-3908(65)90005-5 · DOI · Paper page
- 10.1016/S0079-6123(08)60990-5 · DOI · Paper page
- 10.1136/jnnp.46.10.911 · DOI
- 10.1136/jnnp.46.1.14 · DOI
- 10.1016/S0140-6736(78)90386-0 · DOI · Paper page
- 10.1126/science.7455701 · DOI · Paper page
- 10.1016/S0140-6736(81)90137-9 · DOI
- 10.1016/0024-3205(81)90531-2 · DOI
- 10.1016/0196-9781(82)90162-0 · DOI
- 10.1212/WNL.32.6.674 · DOI
- 10.1002/ana.410120412 · DOI
- 10.1159/000115511 · DOI
- 10.1210/endo-83-2-246 · DOI · Paper page
- 10.1677/joe.0.0600195 · DOI · Paper page
- 10.1677/joe.0.0930319 · DOI · Paper page
- 10.1002/ana.410030306 · doi:10.1002/ana.410030306
- Bie P., 1983, Effect on intravascular pressures of vasopressin and angiotensin II in dogs, Am J Physiol, 25, R906
- 10.1136/bmj.3.5876.375 · DOI · Paper page
- 10.1677/joe.0.0880181 · doi:10.1677/joe.0.0880181
- 10.1016/S0014-4835(77)80008-0 · DOI · Paper page
- 10.1146/annurev.ph.45.030183.000445 · DOI · Paper page
- Collins JM, 1983, Distributed model for drug delivery to CSF and brain tissue, Am J Physiol, 245, R303
- 10.1016/0022-510X(83)90189-2 · doi:10.1016/0022-510x(83)90189-2
- Landgraf A., 1979, Indications for a brain uptake of labelled vasopressin and oxytocin and the problem of the blood‐brain barrier, Endokrinologie, 73, 77
- 10.1016/0006-8993(80)90435-7 · DOI
- 10.1016/0006-8993(81)91199-9 · DOI
- Brownfield MS, 1977, The hypothalamochoroidal tract. I. Immunohistochemical demonstration of neurophysin pathways to telencephalic choroid plexuses and cerebrospinal fluid, Cell Tissue Res, 178, 111
Cited by
Coccaro, E. F., Kavoussi, R. J., Hauger, R. L., Cooper, T. B., & Ferris, C. F. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.8.708 · Cited by 392
Parker, K. J., Oztan, O., Libove, R. A., Mohsin, N., Karhson, D. S., Sumiyoshi, R. D., Summers, J. E., Hinman, K. E., Motonaga, K. S., Phillips, J. M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau7356 · Cited by 185
“This may be because desmopressin is typically administered at bedtime (so prosocial effects would be less evident) and orally (oral desmopressin does not cross the blood-brain barrier) (34).”
BackgroundThe physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors
Juul, K. V., Bichet, D. G., Nielsen, S., & Nørgaard, J. P. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00604.2013 · Cited by 156
“Furthermore, there exist contradictory reports as to whether desmopressin can pass through the blood-brain barrier (36, 51, 107, 110).”
BackgroundCerebrospinal-fluid vasopressin in neurological and psychiatric-disorders
Sorensen, P. S., Gjerris, A., & Hammer, M. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.1.50 · Cited by 103
Neuropsychological effects of vasopressin in healthy humans
Born, J., Pietrowsky, R., & L. Fehm, H. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)61595-2 · Cited by 42
Metadata
- Authors
- SØRENSEN, P. S., VILHARDT, H., GJERRIS, F., & WARBERG, J.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 1984-12
- Volume
- 14
- Issue
- 6
- Pages
- 435-439
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W1984851899
- Cited by
- 38
- References
- 1
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impermeability of the blood‐cerebrospinal fluid barrier to 1‐deamino‐8‐D‐arginine‐vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus. https://app.cochat.ai/papers/10.1111/j.1365-2362.1984.tb01209.x
- The paper
- SØRENSEN, P. S., VILHARDT, H., GJERRIS, F., & WARBERG, J. (1984). Impermeability of the blood‐cerebrospinal fluid barrier to 1‐deamino‐8‐D‐arginine‐vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.1984.tb01209.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.